ClinicalTrials.Veeva

Menu

The Impact of Serial Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation in Healthy Adults

J

Jilin University

Status

Completed

Conditions

Remote Ischemic Conditioning

Treatments

Procedure: Intravenous blood collection
Device: dCA measurement
Device: BB-RIC-D1/LAPUL Medical Devices Co, Ltd, China

Study type

Interventional

Funder types

Other

Identifiers

NCT04899362
SRIC-CA

Details and patient eligibility

About

The purpose of this study is to determine the impact of serial remote ischemic conditioning on dynamic cerebral autoregulation and related hematology indexes in healthy adults.

Full description

Remote ischemic conditioning(RIC) is the phenomenon whereby brief cycles of ischemia and reperfusion, applied to a distant organ, provide protection to the target organ. Dynamic cerebral autoregulation(dCA), a mechanism to maintain the cerebral blood flow, has been proved to be critical for the occurrence,development and prognosis of ischemic neurovascular disease. In this study, we hypothesis that RIC provides neuro-protection by means of improving dCA.

Enrollment

36 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age from 18 to 50,both genders
  • willing to participate in follow-up visits

Exclusion criteria

  • current or having a history of chronic physical diseases or mental diseases
  • suffering from infectious diseases in late one month
  • pregnant and lactating women#
  • smoking or drinking#
  • inability to cooperate sufficiently to complete the dCA examination

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

36 participants in 1 patient group

RIC group
Experimental group
Description:
RIC was induced by 4 cycles of extremities ischemia (5-minute blood-pressure cuff inflation to 200 mm Hg, followed by 5-minute cuff deflation).All subjects will take 14 RIC intervention, blood collection and 10 dCA measurements.
Treatment:
Device: dCA measurement
Device: BB-RIC-D1/LAPUL Medical Devices Co, Ltd, China
Procedure: Intravenous blood collection

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems